instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Pseudomonas infection'? | Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection.
Chronic eosinophilic pneumonia (CEP) is a rare disorder characterized by marked accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid (BALF). Patients with CEP usually respond well ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34306708 | 20,191,931 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 34306771 | 19,669,877 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 34306771 | 19,669,877 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | AMINOCAPROIC ACID, TRANEXAMIC ACID | DrugsGivenReaction | CC BY | 34306771 | 18,733,262 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 34306771 | 19,669,877 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 34306771 | 19,669,877 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 34306771 | 19,669,877 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | AMINOCAPROIC ACID, TRANEXAMIC ACID | DrugsGivenReaction | CC BY | 34306771 | 18,695,106 | 2021 |
What was the outcome of reaction 'Arthralgia'? | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | Recovering | ReactionOutcome | CC BY | 34306771 | 19,669,877 | 2021 |
What was the outcome of reaction 'Hypertension'? | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | Recovering | ReactionOutcome | CC BY | 34306771 | 19,669,877 | 2021 |
What was the outcome of reaction 'Oedema peripheral'? | Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela i... | Recovering | ReactionOutcome | CC BY | 34306771 | 19,669,877 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has been demonstrated to be able to activate complement, making patients with deficiency in negative complement regula... | ECULIZUMAB, RAVULIZUMAB-CWVZ | DrugsGivenReaction | CC BY | 34306774 | 19,701,200 | 2021 |
What was the outcome of reaction 'Pancytopenia'? | Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has been demonstrated to be able to activate complement, making patients with deficiency in negative complement regula... | Not recovered | ReactionOutcome | CC BY | 34306774 | 19,701,200 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma.
Angiosarcomas are vascular malignancies with a tendency to spread extensively both locally and systemically. We report a case of cutaneous angiosarcoma of the face in a 53-year-old man that was originally misdiagnosed as ... | CARBOPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 34306782 | 19,821,851 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma.
Angiosarcomas are vascular malignancies with a tendency to spread extensively both locally and systemically. We report a case of cutaneous angiosarcoma of the face in a 53-year-old man that was originally misdiagnosed as ... | RECEIVED ALONG WITH PACLITAXEL; RECEIVED 9 CYCLES FOLLOWED BY CONSOLIDATION THERAPY | DrugDosageText | CC BY | 34306782 | 19,821,851 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma.
Angiosarcomas are vascular malignancies with a tendency to spread extensively both locally and systemically. We report a case of cutaneous angiosarcoma of the face in a 53-year-old man that was originally misdiagnosed as ... | 50 MILLIGRAM/SQ. METER, CYCLE,RECEIVED 8 CYCLES | DrugDosageText | CC BY | 34306782 | 19,821,851 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary alveolar haemorrhage'. | Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
Immune checkpoint blockade is a rapidly expanding therapeutic modality in oncology. However, its adverse effects extend beyond the cytotoxicity of conventional chemotherapy. Pneumotoxicity associated with immune checkpoint therapy presents a diagnostic conu... | AVELUMAB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34306873 | 19,679,148 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
Immune checkpoint blockade is a rapidly expanding therapeutic modality in oncology. However, its adverse effects extend beyond the cytotoxicity of conventional chemotherapy. Pneumotoxicity associated with immune checkpoint therapy presents a diagnostic conu... | AVELUMAB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34306873 | 19,679,148 | 2021-06 |
What was the outcome of reaction 'Pulmonary alveolar haemorrhage'? | Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
Immune checkpoint blockade is a rapidly expanding therapeutic modality in oncology. However, its adverse effects extend beyond the cytotoxicity of conventional chemotherapy. Pneumotoxicity associated with immune checkpoint therapy presents a diagnostic conu... | Fatal | ReactionOutcome | CC BY | 34306873 | 19,679,148 | 2021-06 |
What was the outcome of reaction 'Respiratory failure'? | Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
Immune checkpoint blockade is a rapidly expanding therapeutic modality in oncology. However, its adverse effects extend beyond the cytotoxicity of conventional chemotherapy. Pneumotoxicity associated with immune checkpoint therapy presents a diagnostic conu... | Fatal | ReactionOutcome | CC BY | 34306873 | 19,679,148 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fev... | CARIPRAZINE, CLOZAPINE, DANTROLENE, FLUPHENAZINE, LORAZEPAM, MIRTAZAPINE | DrugsGivenReaction | CC BY | 34306883 | 19,677,152 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant catatonia'. | Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fev... | CARIPRAZINE, CLOZAPINE, DANTROLENE, FLUPHENAZINE, LORAZEPAM, MIRTAZAPINE | DrugsGivenReaction | CC BY | 34306883 | 19,677,152 | 2021-06 |
What was the dosage of drug 'CARIPRAZINE'? | Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fev... | 3 mg (milligrams). | DrugDosage | CC BY | 34306883 | 19,677,152 | 2021-06 |
What was the dosage of drug 'FLUPHENAZINE'? | Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fev... | 5 mg (milligrams). | DrugDosage | CC BY | 34306883 | 19,677,152 | 2021-06 |
What was the dosage of drug 'MIRTAZAPINE'? | Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fev... | 7.5 mg (milligrams). | DrugDosage | CC BY | 34306883 | 19,677,152 | 2021-06 |
What was the outcome of reaction 'Malignant catatonia'? | Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fev... | Recovered | ReactionOutcome | CC BY | 34306883 | 19,677,152 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic cholecystitis'. | Hemorrhagic Cholecystitis: A Rare Cause of Melena.
Hemorrhagic cholecystitis -- a rare cause of hemobilia and melena -- is an atypical presentation of calculous cholecystitis, associated with significant morbidity and mortality. A 75-year-old woman with multiple comorbidities, who was undergoing dual antiplatelet thera... | ASPIRIN, CEFUROXIME, CLOPIDOGREL BISULFATE, METRONIDAZOLE | DrugsGivenReaction | CC BY | 34306900 | 19,690,637 | 2021-07 |
What was the administration route of drug 'CEFUROXIME'? | Hemorrhagic Cholecystitis: A Rare Cause of Melena.
Hemorrhagic cholecystitis -- a rare cause of hemobilia and melena -- is an atypical presentation of calculous cholecystitis, associated with significant morbidity and mortality. A 75-year-old woman with multiple comorbidities, who was undergoing dual antiplatelet thera... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34306900 | 19,690,637 | 2021-07 |
What was the dosage of drug 'ASPIRIN'? | Hemorrhagic Cholecystitis: A Rare Cause of Melena.
Hemorrhagic cholecystitis -- a rare cause of hemobilia and melena -- is an atypical presentation of calculous cholecystitis, associated with significant morbidity and mortality. A 75-year-old woman with multiple comorbidities, who was undergoing dual antiplatelet thera... | 75 mg (milligrams). | DrugDosage | CC BY | 34306900 | 19,690,637 | 2021-07 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | Hemorrhagic Cholecystitis: A Rare Cause of Melena.
Hemorrhagic cholecystitis -- a rare cause of hemobilia and melena -- is an atypical presentation of calculous cholecystitis, associated with significant morbidity and mortality. A 75-year-old woman with multiple comorbidities, who was undergoing dual antiplatelet thera... | 75 mg (milligrams). | DrugDosage | CC BY | 34306900 | 19,690,637 | 2021-07 |
What was the outcome of reaction 'Haemorrhagic cholecystitis'? | Hemorrhagic Cholecystitis: A Rare Cause of Melena.
Hemorrhagic cholecystitis -- a rare cause of hemobilia and melena -- is an atypical presentation of calculous cholecystitis, associated with significant morbidity and mortality. A 75-year-old woman with multiple comorbidities, who was undergoing dual antiplatelet thera... | Recovered | ReactionOutcome | CC BY | 34306900 | 19,690,637 | 2021-07 |
What was the administration route of drug 'AMPHOTERICIN B'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34307009 | 19,666,189 | 2021-09 |
What was the administration route of drug 'DEXAMETHASONE'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34307009 | 19,666,189 | 2021-09 |
What was the administration route of drug 'FLUCONAZOLE'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34307009 | 19,666,189 | 2021-09 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | UNKNOWN | DrugDosageText | CC BY | 34307009 | 19,612,728 | 2021-09 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | UNKNOWN | DrugDosageText | CC BY | 34307009 | 19,612,728 | 2021-09 |
What was the outcome of reaction 'Cerebral infarction'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Fatal | ReactionOutcome | CC BY | 34307009 | 19,636,807 | 2021-09 |
What was the outcome of reaction 'Drug ineffective'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Fatal | ReactionOutcome | CC BY | 34307009 | 19,691,909 | 2021-09 |
What was the outcome of reaction 'Haemophagocytic lymphohistiocytosis'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Fatal | ReactionOutcome | CC BY | 34307009 | 19,636,807 | 2021-09 |
What was the outcome of reaction 'Histoplasmosis disseminated'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Fatal | ReactionOutcome | CC BY | 34307009 | 19,636,807 | 2021-09 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Fatal | ReactionOutcome | CC BY | 34307009 | 19,636,807 | 2021-09 |
What was the outcome of reaction 'Renal injury'? | Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis.
Histoplasmosis-associated hemophagocytic lymphohistiocytosis is a rate but lethal disease in immunocompromised hosts. Unusual clinical presentations make diagnosing invasive fungal infection even more chall... | Fatal | ReactionOutcome | CC BY | 34307009 | 19,636,807 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | ACETAMINOPHEN, ACYCLOVIR, AMPHOTERICIN B, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CHLORPROMAZINE, DEXAMETHASONE, DIPHENHYDRAMINE, FLUCONAZOLE, IBUPROFEN, KETOROLAC TROMETHAMINE, MANNITOL, MILTEFOSINE, ONDANSETRON, PENICILLIN G, RIFAMPIN, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | ACETAMINOPHEN, ACYCLOVIR, AMPHOTERICIN B, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CHLORPROMAZINE, DEXAMETHASONE, DIPHENHYDRAMINE, FLUCONAZOLE, IBUPROFEN, KETOROLAC TROMETHAMINE, MANNITOL, MILTEFOSINE, ONDANSETRON, PENICILLIN G, RIFAMPIN, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'ACETAMINOPHEN'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'ACYCLOVIR'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'AMPHOTERICIN B'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'AZITHROMYCIN ANHYDROUS'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'CEFTRIAXONE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'CHLORPROMAZINE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'DIPHENHYDRAMINE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'FLUCONAZOLE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'IBUPROFEN'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'KETOROLAC TROMETHAMINE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'MANNITOL'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'MILTEFOSINE'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'ONDANSETRON'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'PENICILLIN G'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'RIFAMPIN'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the dosage of drug 'VANCOMYCIN'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | A case report of primary amebic meningoencephalitis in North Florida.
Primary amebic meningoencephalitis is a rare, usually fatal disease, caused by Naegleria fowleri. This case highlights the challenging clinicopathologic diagnosis in a 13-year-old boy who swam in freshwater in northern Florida where a previous case h... | Fatal | ReactionOutcome | CC BY-NC-ND | 34307045 | 19,839,304 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metaplasia'. | A unique presentation of a rare renal cancer: Appearance of bone metaplasia in tubulocystic renal cell carcinoma.
Tubulocystic renal cell carcinoma is a rare cancer that was not defined as a distinct entity until the early 2000s. Due to the recency of its classification, it remains poorly understood and leaves much roo... | DICYCLOMINE HYDROCHLORIDE, ESCITALOPRAM OXALATE, ESZOPICLONE, METOPROLOL SUCCINATE | DrugsGivenReaction | CC BY-NC-ND | 34307049 | 19,899,523 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrectomy'. | A unique presentation of a rare renal cancer: Appearance of bone metaplasia in tubulocystic renal cell carcinoma.
Tubulocystic renal cell carcinoma is a rare cancer that was not defined as a distinct entity until the early 2000s. Due to the recency of its classification, it remains poorly understood and leaves much roo... | DICYCLOMINE HYDROCHLORIDE, ESCITALOPRAM OXALATE, ESZOPICLONE, METOPROLOL SUCCINATE | DrugsGivenReaction | CC BY-NC-ND | 34307049 | 19,899,523 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal cell carcinoma'. | A unique presentation of a rare renal cancer: Appearance of bone metaplasia in tubulocystic renal cell carcinoma.
Tubulocystic renal cell carcinoma is a rare cancer that was not defined as a distinct entity until the early 2000s. Due to the recency of its classification, it remains poorly understood and leaves much roo... | DICYCLOMINE HYDROCHLORIDE, ESCITALOPRAM OXALATE, ESZOPICLONE, METOPROLOL SUCCINATE | DrugsGivenReaction | CC BY-NC-ND | 34307049 | 19,899,523 | 2021-11 |
What was the outcome of reaction 'Metaplasia'? | A unique presentation of a rare renal cancer: Appearance of bone metaplasia in tubulocystic renal cell carcinoma.
Tubulocystic renal cell carcinoma is a rare cancer that was not defined as a distinct entity until the early 2000s. Due to the recency of its classification, it remains poorly understood and leaves much roo... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY-NC-ND | 34307049 | 19,899,523 | 2021-11 |
What was the outcome of reaction 'Nephrectomy'? | A unique presentation of a rare renal cancer: Appearance of bone metaplasia in tubulocystic renal cell carcinoma.
Tubulocystic renal cell carcinoma is a rare cancer that was not defined as a distinct entity until the early 2000s. Due to the recency of its classification, it remains poorly understood and leaves much roo... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY-NC-ND | 34307049 | 19,899,523 | 2021-11 |
What was the outcome of reaction 'Renal cell carcinoma'? | A unique presentation of a rare renal cancer: Appearance of bone metaplasia in tubulocystic renal cell carcinoma.
Tubulocystic renal cell carcinoma is a rare cancer that was not defined as a distinct entity until the early 2000s. Due to the recency of its classification, it remains poorly understood and leaves much roo... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY-NC-ND | 34307049 | 19,899,523 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy.
Sarcopenia has been associated with treatment-related toxicities and poor survival in cancer patients. Our aim was to investigate the prevalence of sarcopenia in posto... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 34307131 | 20,163,017 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tracheo-oesophageal fistula'. | Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy.
Sarcopenia has been associated with treatment-related toxicities and poor survival in cancer patients. Our aim was to investigate the prevalence of sarcopenia in posto... | CISPLATIN, DOCETAXEL | DrugsGivenReaction | CC BY | 34307131 | 20,162,896 | 2021 |
What was the outcome of reaction 'Pulmonary embolism'? | Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy.
Sarcopenia has been associated with treatment-related toxicities and poor survival in cancer patients. Our aim was to investigate the prevalence of sarcopenia in posto... | Fatal | ReactionOutcome | CC BY | 34307131 | 20,163,017 | 2021 |
What was the outcome of reaction 'Tracheo-oesophageal fistula'? | Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy.
Sarcopenia has been associated with treatment-related toxicities and poor survival in cancer patients. Our aim was to investigate the prevalence of sarcopenia in posto... | Fatal | ReactionOutcome | CC BY | 34307131 | 20,162,896 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory failure'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coagulopathy'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,044,995 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematocrit decreased'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,044,995 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,044,995 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Patent ductus arteriosus'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia pseudomonal'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,044,995 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature labour'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,044,995 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | AMPICILLIN, AZITHROMYCIN, CEFOTAXIME SODIUM, DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IBUPROFEN, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34307227 | 20,089,715 | 2021 |
What was the outcome of reaction 'Low birth weight baby'? | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | Fatal | ReactionOutcome | CC BY | 34307227 | 20,089,715 | 2021 |
What was the outcome of reaction 'Pneumonia pseudomonal'? | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | Fatal | ReactionOutcome | CC BY | 34307227 | 20,089,715 | 2021 |
What was the outcome of reaction 'Premature baby'? | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | Fatal | ReactionOutcome | CC BY | 34307227 | 20,089,715 | 2021 |
What was the outcome of reaction 'Sepsis'? | Pseudomonas aeruginosa necrotizing bronchopneumonia.
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are a... | Fatal | ReactionOutcome | CC BY | 34307227 | 20,089,715 | 2021 |
What was the administration route of drug 'CABERGOLINE'? | Empty Sella Syndrome as a Window Into the Neuroprotective Effects of Prolactin.
Background: The goal of this study was to relate diffusion MR measures of white matter integrity of the retinofugal visual pathway with prolactin levels in a patient with downward herniation of the optic chiasm secondary to medical treatmen... | Oral | DrugAdministrationRoute | CC BY | 34307410 | 20,665,464 | 2021 |
What was the outcome of reaction 'Empty sella syndrome'? | Empty Sella Syndrome as a Window Into the Neuroprotective Effects of Prolactin.
Background: The goal of this study was to relate diffusion MR measures of white matter integrity of the retinofugal visual pathway with prolactin levels in a patient with downward herniation of the optic chiasm secondary to medical treatmen... | Recovering | ReactionOutcome | CC BY | 34307410 | 20,658,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient.
Here we report a critically ill patient who was cured of SARS-CoV-2 infection in Changsha, China. A 66-year-old Chinese woman, with no significant past medical history, developed severe pneumoni... | COVID-19 CONVALESCENT PLASMA, DAPTOMYCIN, HUMAN IMMUNOGLOBULIN G, LINEZOLID, MEROPENEM, METHYLPREDNISOLONE, MOXIFLOXACIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, POLYMYXIN B, THYMALFASIN, TIGECYCLINE, UMIFENOVIR, VORICONAZOLE | DrugsGivenReaction | CC BY | 34307417 | 20,937,367 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient.
Here we report a critically ill patient who was cured of SARS-CoV-2 infection in Changsha, China. A 66-year-old Chinese woman, with no significant past medical history, developed severe pneumoni... | COVID-19 CONVALESCENT PLASMA, DAPTOMYCIN, HUMAN IMMUNOGLOBULIN G, LINEZOLID, MEROPENEM, METHYLPREDNISOLONE, MOXIFLOXACIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, POLYMYXIN B, THYMALFASIN, TIGECYCLINE, UMIFENOVIR, VORICONAZOLE | DrugsGivenReaction | CC BY | 34307417 | 20,937,367 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report.
Background: Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner as per evidence-based clinical guidelines, is an important barrier limiting optimal care in ... | ROSUVASTATIN | DrugsGivenReaction | CC BY | 34307425 | 20,063,489 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhabdomyolysis'. | Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report.
Background: Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner as per evidence-based clinical guidelines, is an important barrier limiting optimal care in ... | ROSUVASTATIN | DrugsGivenReaction | CC BY | 34307425 | 20,063,489 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report.
Background: Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner as per evidence-based clinical guidelines, is an important barrier limiting optimal care in ... | EZETIMIBE | DrugsGivenReaction | CC BY | 34307425 | 19,734,434 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report.
Background: Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner as per evidence-based clinical guidelines, is an important barrier limiting optimal care in ... | Recovered | ReactionOutcome | CC BY | 34307425 | 20,063,489 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.